It lowered the price of a 2.5-milligram dose of Zepbound to $349 a month, and of a 5-milligram dose to $499 a month
This means: You pay the full cash price directly to the compounding pharmacy or telehealth platform TRICARE does not process a claim The cost does not count toward your TRICARE deductible or out-of-pocket maximum You do not need prior authorization You do not need a diabetes diagnosis The typical cost structure for compounded tirzepatide through platforms like FormBlends: Initial consultation with licensed provider: $0 to $49 Monthly medication cost: $297 to $399 depending on dose Shipping: included Ongoing provider check-ins: included For a 12-month course, total cost is approximately $3,564 to $4,788, or 73% to 78% less than brand-name Zepbound paid out of pocket

To me, this looks more like desperation and an attempt by Novo to protect its revenue stream than a serious scientific argument. Brunner pointed out that the FDAs Adverse Events Reporting System (FAERS) database shows that patient reports from those taking compounded and branded semaglutide are remarkably similar. Compounding pharmacies have been allowed to make their knockoff versions of the drugs since the branded products were added to the FDAs shortage list
For instance, when transitioning to semaglutide, your provider might start you at 0.5 mg weekly and then titrate as needed
Cardiovascular exercise (walking, cycling, swimming) contributes too, mainly by increasing your overall calorie burn and improving cardiovascular health
142 Both conditions appear to synergistically contribute to liver disease progression and poor prognosis